320 related articles for article (PubMed ID: 27464726)
1. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
Dimitriadis GK; Kyrou I; Randeva HS
Curr Pharm Des; 2016; 22(36):5535-5546. PubMed ID: 27464726
[TBL] [Abstract][Full Text] [Related]
2. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
Spritzer PM; Lecke SB; Satler F; Morsch DM
Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
4. Cardiometabolic aspects of the polycystic ovary syndrome.
Randeva HS; Tan BK; Weickert MO; Lois K; Nestler JE; Sattar N; Lehnert H
Endocr Rev; 2012 Oct; 33(5):812-41. PubMed ID: 22829562
[TBL] [Abstract][Full Text] [Related]
5. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
6. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
[TBL] [Abstract][Full Text] [Related]
7. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte biology in polycystic ovary syndrome.
Barber TM; Franks S
Mol Cell Endocrinol; 2013 Jul; 373(1-2):68-76. PubMed ID: 23084978
[TBL] [Abstract][Full Text] [Related]
9. Insulin and the polycystic ovary syndrome.
Macut D; Bjekić-Macut J; Rahelić D; Doknić M
Diabetes Res Clin Pract; 2017 Aug; 130():163-170. PubMed ID: 28646699
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome.
de Medeiros SF; Rodgers RJ; Norman RJ
Hum Reprod Update; 2021 Jun; 27(4):771-796. PubMed ID: 33764457
[TBL] [Abstract][Full Text] [Related]
11. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue dysfunction in polycystic ovary syndrome.
Villa J; Pratley RE
Curr Diab Rep; 2011 Jun; 11(3):179-84. PubMed ID: 21424395
[TBL] [Abstract][Full Text] [Related]
13. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
Bril F; Ezeh U; Amiri M; Hatoum S; Pace L; Chen YH; Bertrand F; Gower B; Azziz R
J Clin Endocrinol Metab; 2023 Dec; 109(1):10-24. PubMed ID: 37329216
[TBL] [Abstract][Full Text] [Related]
14. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Walsh M; Taylor AE; Manolopoulos KN; Allwood JW; Semple RK; Hebenstreit D; Dunn WB; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2017 Sep; 102(9):3327-3339. PubMed ID: 28645211
[TBL] [Abstract][Full Text] [Related]
15. Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).
Baranova A; Tran TP; Afendy A; Wang L; Shamsaddini A; Mehta R; Chandhoke V; Birerdinc A; Younossi ZM
J Transl Med; 2013 May; 11():133. PubMed ID: 23721173
[TBL] [Abstract][Full Text] [Related]
16. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.
Marino JS; Iler J; Dowling AR; Chua S; Bruning JC; Coppari R; Hill JW
PLoS One; 2012; 7(10):e48643. PubMed ID: 23119079
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
[TBL] [Abstract][Full Text] [Related]
19. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome.
Echiburú B; Pérez-Bravo F; Galgani JE; Sandoval D; Saldías C; Crisosto N; Maliqueo M; Sir-Petermann T
Steroids; 2018 Feb; 130():15-21. PubMed ID: 29273198
[TBL] [Abstract][Full Text] [Related]
20. Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.
González F
Steroids; 2012 Mar; 77(4):300-5. PubMed ID: 22178787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
